145 related articles for article (PubMed ID: 36633771)
1. Wild-type IDH1 Knockout Leads to G0/G1 Arrest, Impairs Cancer Cell Proliferation, Altering Glycolysis, and the TCA Cycle in Colon Cancer.
Atalay EB; Senturk S; Kayali HA
Biochem Genet; 2023 Aug; 61(4):1470-1486. PubMed ID: 36633771
[TBL] [Abstract][Full Text] [Related]
2. The elevated D-2-hydroxyglutarate level found as a characteristic metabolic change of colon cancer in both in vitro and in vivo models.
Atalay EB; Kayali HA
Biochem Biophys Res Commun; 2022 Oct; 627():191-199. PubMed ID: 36049357
[TBL] [Abstract][Full Text] [Related]
3. Mutation of
Su L; Zhang X; Zheng L; Wang M; Zhu Z; Li P
Front Endocrinol (Lausanne); 2020; 11():189. PubMed ID: 32373065
[No Abstract] [Full Text] [Related]
4. U3 snoRNA-mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild-type glioblastoma cells.
Dong W; Liu Y; Wang P; Ruan X; Liu L; Xue Y; Ma T; E T; Wang D; Yang C; Lin H; Song J; Liu X
CNS Neurosci Ther; 2023 Oct; 29(10):2811-2825. PubMed ID: 37066523
[TBL] [Abstract][Full Text] [Related]
5. IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in Glioma cells in vitro and in vivo.
Wang JB; Dong DF; Wang MD; Gao K
Asian Pac J Cancer Prev; 2014; 15(1):427-32. PubMed ID: 24528069
[TBL] [Abstract][Full Text] [Related]
6. Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
Izquierdo-Garcia JL; Cai LM; Chaumeil MM; Eriksson P; Robinson AE; Pieper RO; Phillips JJ; Ronen SM
PLoS One; 2014; 9(9):e108289. PubMed ID: 25243911
[TBL] [Abstract][Full Text] [Related]
7. Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation.
Zhou L; Wang Z; Hu C; Zhang C; Kovatcheva-Datchary P; Yu D; Liu S; Ren F; Wang X; Li Y; Hou X; Piao H; Lu X; Zhang Y; Xu G
J Proteome Res; 2019 Mar; 18(3):960-969. PubMed ID: 30596429
[TBL] [Abstract][Full Text] [Related]
8. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF
Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784
[TBL] [Abstract][Full Text] [Related]
9. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Gonthier K; Weidmann C; Berthiaume L; Jobin C; Lacouture A; Lafront C; Harvey M; Neveu B; Loehr J; Bergeron A; Fradet Y; Lacombe L; Riopel J; Latulippe É; Atallah C; Shum M; Lambert JP; Pouliot F; Pelletier M; Audet-Walsh É
Mol Oncol; 2023 Oct; 17(10):2109-2125. PubMed ID: 37086156
[TBL] [Abstract][Full Text] [Related]
10. Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle.
Liu J; Peng Y; Shi L; Wan L; Inuzuka H; Long J; Guo J; Zhang J; Yuan M; Zhang S; Wang X; Gao J; Dai X; Furumoto S; Jia L; Pandolfi PP; Asara JM; Kaelin WG; Liu J; Wei W
Cell Res; 2021 Jan; 31(1):80-93. PubMed ID: 32669607
[TBL] [Abstract][Full Text] [Related]
11. Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level.
Dekker LJM; Wu S; Jurriëns C; Mustafa DAN; Grevers F; Burgers PC; Sillevis Smitt PAE; Kros JM; Luider TM
FASEB J; 2020 Mar; 34(3):3646-3657. PubMed ID: 31960518
[TBL] [Abstract][Full Text] [Related]
12. Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.
Dahl ES; Buj R; Leon KE; Newell JM; Imamura Y; Bitler BG; Snyder NW; Aird KM
Mol Cancer Res; 2019 Aug; 17(8):1710-1720. PubMed ID: 31110157
[TBL] [Abstract][Full Text] [Related]
13. Chronic nickel (II) exposure induces the stemness properties of cancer cells through repressing isocitrate dehydrogenase (IDH1).
Wang L; He S; Xiong Z; Lu J; Lin Y; Jin H; Yang L
Ecotoxicol Environ Saf; 2021 Apr; 213():112031. PubMed ID: 33578097
[TBL] [Abstract][Full Text] [Related]
14. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia.
Reitman ZJ; Duncan CG; Poteet E; Winters A; Yan LJ; Gooden DM; Spasojevic I; Boros LG; Yang SH; Yan H
J Biol Chem; 2014 Aug; 289(34):23318-28. PubMed ID: 24986863
[TBL] [Abstract][Full Text] [Related]
16. Profiling the Effect of Targeting Wild Isocitrate Dehydrogenase 1 (IDH1) on the Cellular Metabolome of Leukemic Cells.
Shait Mohammed MR; Alzahrani F; Hosawi S; Choudhry H; Khan MI
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743098
[TBL] [Abstract][Full Text] [Related]
17. Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation.
Fujiwara H; Tateishi K; Misumi K; Hayashi A; Igarashi K; Kato H; Nakatsuka T; Suzuki N; Yamamoto K; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Ijichi H; Kogure H; Nakai Y; Isayama H; Hasegawa K; Fukayama M; Soga T; Koike K
Sci Rep; 2019 Dec; 9(1):18859. PubMed ID: 31827136
[TBL] [Abstract][Full Text] [Related]
18. Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence.
Zhan D; Ma D; Wei S; Lal B; Fu Y; Eberhart C; Laterra J; Ying M; Li Y; Meeker A; Lopez-Bertoni H; Xia S
Mol Cancer Res; 2021 Nov; 19(11):1878-1888. PubMed ID: 34348994
[TBL] [Abstract][Full Text] [Related]
19. RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer.
Zarei M; Lal S; Vaziri-Gohar A; O'Hayer K; Gunda V; Singh PK; Brody JR; Winter JM
Mol Cancer Res; 2019 Feb; 17(2):508-520. PubMed ID: 30266754
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.
Gonthier K; Poluri RTK; Weidmann C; Tadros M; Audet-Walsh É
Mol Cancer Res; 2019 Aug; 17(8):1699-1709. PubMed ID: 31068457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]